Abstract:Purpose: We previously reported that activated T cells accumulate in the perihematomal regions after Intracerebral hemorrhage (ICH) and aggravate hemorrhagic brain injury. However, brain-infiltrating T cells precise activation mechanisms and resulting pathological impacts remain largely unexplored. This study aims to address these knowledge gaps. Methodology: ICH was induced via standard collagenase injection in male C57BL/6J mice (10 weeks old). Activation pathways of T cells were analyzed through single-cell RNA data (GSE230414). We assessed T cell receptor (TCR) activation, pro-inflammatory cytokines expression, and immune cell infiltration via flow cytometry and immunostaining at 1- and 3-days post-ICH. Neurobehavioral evaluations were conducted at 1-, 3-, 7-, and 14-days post-ICH. TCR activation was pharmacologically inhibited using the TCR-specific inhibitor AX-024, administered (10 mg/kg, i.p.) one hour after ICH. Results: Single-cell transcriptomic analysis revealed an upregulation of the TCR pathway in activated T cells following ICH in mice. Flow cytometry and immunostaining validated TCR activation markers (p-CD3, p-Zap70) in ICH mouse models. These findings suggest that TCR activation likely plays a central role in the activation of brain-infiltrating T cells. In the subsequent experiment, we explored the pathological implications of TCR activation on T cell activation, leukocyte brain infiltration, and neurological outcomes post-ICH. We found that administration of AX-024 substantially inhibited TCR activation (CD69 expression) and expression of pro-inflammatory cytokines (IL-17, IL-1β) in brain-infiltrating T cells at 1- and 3-days post-ICH. Notably, AX-024 administration also significantly decreased the infiltration of other leukocytes and remarkably enhanced long-term sensorimotor and cognitive function up to 14 days after ICH. Discussion: This study underscores TCR activation as a pivotal mechanism driving activation of brain-infiltrating T cells following ICH. Inhibiting TCR activation through AX-024 proves beneficial for improving neurological outcomes after ICH. However, further investigations are warranted to comprehensively elucidate the intricate underlying pathological mechanisms.

Abstract TP239: Cholesterol And LXR Signaling In The Macrophage Response To Intracerebral Hemorrhage-relevant Stimulation

Cholesterol, LXR activation, and myelin uptake in the macrophage response to diverse signals

Abstract WP162: Myelin Suppresses Macrophage Responses to Diverse Stimuli

Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages

Clearance of Neutrophils From ICH-Affected Brain by Macrophages Is Beneficial and Is Assisted by Lactoferrin and CD91

Abstract 99: Single Cell RNA-Sequencing Reveals Array Of Immune Activation States In Intracerebral Hemorrhage

Pharmacological Activation of RXR-α Promotes Hematoma Absorption in a PPAR-γ-Dependent Pathway after Intracerebral Hemorrhage

Characteristics of activation of monocyte-derived macrophages versus microglia after mouse experimental intracerebral hemorrhage

Abstract TP257: Apoptotic Erythrocytes Attenuate Macrophages Proinflammatory Phenotype in Intracerebral Hemorrhage

Abstract WMP74: Inhibition of T Cell Receptor Activation Improves Neurological Outcomes After Intracerebral Hemorrhage

Blockade of High Mobility Group Box-1 Signaling Via the Receptor for Advanced Glycation End-Products Ameliorates Inflammatory Damage after Acute Intracerebral Hemorrhage

Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage

Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production

Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (Nf-Κb)-dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage

Divergent Functions of Tissue-Resident and Blood-Derived Macrophages in the Hemorrhagic Brain

Untangling the inflammatory responses of liver x receptor (LXR) activation in human macrophages

Quantitative Profiling of Oxylipins in Acute Experimental Intracerebral Hemorrhage

418 CXCL-10 Influences Local Regulation of Neuroinflammation After Intracranial Hemorrhage

Glucocorticoid Treatment Inhibits Intracerebral Hemorrhage-Induced Inflammation by Targeting the Microrna-155/Socs-1 Signaling Pathway

Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage

Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance